Exploring how specific proteins affect liver cell activation in alcohol-related liver disease
Investigating the Role of Wnt3a and Wnt5a as Factors of Hepatic Stellate Cell Activation in Alcohol-Related Liver Fibrosis
This study is looking at how two proteins, Wnt3a and Wnt5a, affect liver cells that can cause scarring in people with alcohol-related liver disease, with the hope of finding new ways to help treat this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11125748 on NIH RePORTER |
What this research studies
This research investigates the role of two proteins, Wnt3a and Wnt5a, in the activation of liver cells that contribute to scarring in patients with alcohol-related liver disease. The study aims to understand how these proteins influence the progression of liver damage caused by alcohol, which is a significant health issue in the United States. By examining the mechanisms of liver cell activation and fibrosis, the research seeks to identify potential therapeutic targets that could lead to new treatment options for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol-related liver disease who are experiencing liver scarring.
Not a fit: Patients with liver disease not related to alcohol or those who have already undergone liver transplantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or reverse liver scarring in patients with alcohol-related liver disease.
How similar studies have performed: While the specific focus on Wnt proteins in the context of alcohol-related liver disease is relatively novel, similar research has shown promise in understanding liver fibrosis mechanisms.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Rutt, Lauren — University of Colorado Denver
- Study coordinator: Rutt, Lauren
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.